Studies have demonstrated that cancer-specific transcription-induced chimeric RNA-loaded DC-derived exosomes enhance CD8+ T-cell-mediated anticancer immunity and suppress tumour progression in esophageal cancer [64]. This evidence concerns the gene CD8A and neoplasm.